Home › Sovrappeso › Arizona › Phoenix
Studi clinici su Sovrappeso a Phoenix, AZ
15 studi su Sovrappeso cercano partecipanti presso sedi a Phoenix e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
In reclutamentoFase 3
- Absolute Clinical Research, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
In reclutamentoFase 3
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
In reclutamentoFase 3
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
In reclutamentoFase 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
In reclutamentoFase 3
- Elite Clinical Studies, LLC, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 3
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
In reclutamentoFase 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
In reclutamentoFase 3Volontari sani benvenuti
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
In reclutamentoFase 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
In reclutamentoFase 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
In reclutamentoStudio osservazionale
- Exponent Phoenix, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
In reclutamentoFase 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Studi su Sovrappeso in altre città
- San Antonio, TX34 studi
- Houston, TX33 studi
- Chicago, IL28 studi
- Orlando, FL27 studi
- Las Vegas, NV23 studi
- Miami, FL23 studi
- Atlanta, GA20 studi
- Dallas, TX20 studi
- New York City, NY19 studi
- Jacksonville, FL19 studi
- Washington, DC19 studi
- Austin, TX18 studi
Altri studi a Phoenix
- Cancro al seno25 studi
- Cancro colorettale25 studi
- Obesità22 studi
- Cancro del polmone non a piccole cellule20 studi
- Cancro metastatico20 studi
- Insufficienza cardiaca18 studi
- Cancro alla prostata17 studi
- Cancro (tutti i tipi)17 studi
- Mieloma multiplo16 studi
- Cancro pancreatico16 studi
- Malattie cardiovascolari16 studi
- Morbo di Alzheimer15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.